Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease-Reference-Cited by-同舟云学术

Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease

Published:2019-05-27 Issue:9 Volume:23 Page:1130-1140
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Kocyigit Ismail^ORCID,Ozturk Fahir,Eroglu Eray,Karaca Zuleyha,Kaynar Ahmet Safa,Cetin Mustafa,Tokgoz Bulent,Sipahioglu Murat Hayri,Bayramov Ruslan,Sen Ahmet,Oymak Oktay,Ecder Tevfik,Axelsson Jonas

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10157-019-01748-z.pdf

Reference23 articles.

1. Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med. 1993;5:332–42.

2. Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int. 2009;2:149–68.

3. Ecder T, Schrier RW. Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease. Nat Rev Nephrol. 2009;4:221–8.

4. Ecder T, Schrier RW. Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Nephrol. 2001;1:194–200.

5. Lin CC, Kurashige M, Liu Y, Terabayashi T, Ishimoto Y, Wang T, et al. A cleavage product of Polycystin-1 is a mitochondrial matrix protein that affects mitochondrial morphology and function when heterologously expressed. Sci Rep. 2018;8(1):2743.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin therapy in patients with early-stage autosomal dominant polycystic kidney disease: Design and baseline characteristics;Contemporary Clinical Trials;2024-02

2. The association between serum Perilipin-2 and kidney disease progression of patients with autosomal dominant polycystic kidney disease;DAHUDER Medical Journal;2024-01-29

3. Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers;Frontiers in Pediatrics;2023-11-10

4. A Systematic Review of Reported Outcomes in ADPKD Studies;Kidney International Reports;2022-09

5. Involvement of Inflammasome Components in Kidney Disease;Antioxidants;2022-01-27